Guijarro L, Couvineau A, Calvo J R, Laburthe M
Unité de Recherches sur la Différenciation et la Neuroendocrinologie des Cellules Digestives, INSERM, Villejuif, France.
Regul Pept. 1989 Apr;25(1):37-50. doi: 10.1016/0167-0115(89)90246-2.
Vasoactive intestinal peptide (VIP) receptors were solubilized from rat liver using the zwitterionic detergent CHAPS. Optimal conditions of solubilization were obtained with 5 mM CHAPS and 2.5 mg protein/ml. The binding of 125I-VIP to CHAPS extracts was time- and pH-dependent, saturable and reversible. The following order of potency of unlabeled VIP-related peptides for inhibiting 125I-VIP binding was observed: VIP greater than helodermin greater than peptide histidine isoleucine amide (PHI) greater than rat growth hormone releasing factor (rGRF) greater than secretin. This peptide specificity is identical to that of rat liver membrane-bound receptors. VIP binding activity in the CHAPS extract was destroyed by trypsin or dithiothreitol in accordance with the known sensitivity of membrane-bound receptors to these agents. VIP receptors in CHAPS extracts were stable for at least 5 days at 4 degrees C. Scatchard analysis of equilibrium binding data indicated the presence in CHAPS extracts of high (H) and low (L) affinity binding sites with the following characteristics: KdH = 0.27 nM and BmH = 34 fmol/mg protein; KdL = 51 nM and BmL = 1078 fmol/mg protein. The guanine nucleotide GTP inhibited 125I-VIP binding to soluble receptors and enhanced the dissociation of soluble VIP-receptor complexes, suggesting that GTP-binding proteins were functionally associated with VIP receptors in solution. Gel filtration of solubilized VIP receptors on Sephacryl S-300 revealed a single binding component with a Stokes radius of 6.1 nm. It is concluded that active VIP receptors can be extracted from liver membranes by CHAPS. The availability of this CHAPS-soluble, stable and functional receptor from a tissue which can be obtained in large amounts represents a major step toward the purification of VIP receptors.
使用两性离子去污剂CHAPS从大鼠肝脏中溶解血管活性肠肽(VIP)受体。在5 mM CHAPS和2.5 mg蛋白质/毫升的条件下获得了最佳溶解条件。125I-VIP与CHAPS提取物的结合具有时间和pH依赖性,可饱和且可逆。观察到未标记的VIP相关肽抑制125I-VIP结合的效力顺序如下:VIP大于蛙皮素大于肽组氨酸异亮氨酸酰胺(PHI)大于大鼠生长激素释放因子(rGRF)大于促胰液素。这种肽特异性与大鼠肝细胞膜结合受体的特异性相同。根据膜结合受体对这些试剂的已知敏感性,CHAPS提取物中的VIP结合活性被胰蛋白酶或二硫苏糖醇破坏。CHAPS提取物中的VIP受体在4℃下至少稳定5天。对平衡结合数据的Scatchard分析表明,CHAPS提取物中存在高(H)和低(L)亲和力结合位点,其特征如下:KdH = 0.27 nM,BmH = 34 fmol/毫克蛋白质;KdL = 51 nM,BmL = 1078 fmol/毫克蛋白质。鸟嘌呤核苷酸GTP抑制125I-VIP与可溶性受体的结合,并增强可溶性VIP-受体复合物的解离,表明GTP结合蛋白在溶液中与VIP受体功能相关。在Sephacryl S-300上对溶解的VIP受体进行凝胶过滤,显示出一个斯托克斯半径为6.1 nm的单一结合成分。结论是活性VIP受体可以通过CHAPS从肝细胞膜中提取出来。从大量可获得的组织中获得这种CHAPS可溶、稳定且有功能的受体,是朝着纯化VIP受体迈出的重要一步。